In the present study, AHR was decreased by oral administration of K37, suggesting its anti-allergy effects which may be attributed to the reduction of Th2 cytokines and eotaxin well known to play important roles in the development of AHR [38]. This evidence concerns the gene CCL11 and allergic disease.